FDA Approves New Indication For Baracitinib As Treatment For Certain Adults Hospitalized With COVID-19

Healio (5/11) reports, “The FDA has approved a new indication for [baracitinib] Olumiant as a treatment for adults hospitalized with COVID-19 who require supplemental oxygen, noninvasive or invasive mechanical ventilation, or extracorporeal membrane oxyge...